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Abstract 
Background: Accumulating evidence indicates a strong correlation between allergic disease and cardiovascular 
risks. In spite of this, the data concerning the association between allergic rhinitis (AR) and cardiovascular risks is 
sparse and conflicting. This study aimed to investigate the association between AR prevalence and metabolic syn-
drome (MetS) in a large-scale, population-based survey, while considering the relevant risk factors.
Methods: A nationwide cross-sectional study was conducted based on data from 30,590 subjects aged 19 years and 
older, from the Korean National Health and Nutrition Survey 2007–2013. The odds ratios (ORs) and 95 % confidence 
intervals (CIs) of AR prevalence, based on MetS status and the presence of any MetS component, were calculated 
using multiple logistic regression analyses.
Results: Regarding the characteristics of patients with AR and/or MetS, some variables had significant associations 
with disease in inverse directions for AR and MetS. Multivariate logistic analysis, with adjustments for demographic 
variables and health habits, indicated that AR prevalence was significantly lower in subjects with MetS (OR 0.84; 
95 % CI 0.76–0.93), high blood pressure (OR 0.85; 95 % CI 0.77–0.94), or impaired fasting glucose (OR 0.81; 95 % CI 
0.73–0.89). Furthermore, high blood pressure and impaired fasting glucose were significant predictors for reduced AR 
prevalence, independently of other MetS components.
Conclusion: In this population, AR was diagnosed less frequently in subjects with metabolic conditions. Well-
designed prospective studies allowing for medical service utilization and collaborative basic research are warranted to 
elucidate the mechanism responsible for this inverse relationship.
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Background
Extensive studies have revealed that asthma patients are 
at greater risk of cardiovascular disease (CVD), with mul-
tiple mechanisms proposed [1]. Allergic rhinitis (AR) is 
believed to be an intermediate state between the nor-
mal healthy condition and clinical asthma [2], and it has 
been shown that individuals with AR are at greater risk 
of developing asthma [3]. AR has been suggested to be 
associated with CVD risks in a similar fashion [4]. The 
basis for this potential association is that individuals with 
significant AR symptoms are more likely to be habitual 
snorers, which then leads to higher blood pressure (BP). 
But, the findings of previous studies examining BP of 
AR patients are conflicting [5, 6]. Likewise, inconsistent 
results have been obtained with regard to the influence 
of AR history on CVD. In a prospective cohort study, 
participants with a history of hay fever had an adjusted 
hazard ratio of 1.87 for a stroke versus those without hay 
fever [7]. However, a recent nested case–control study 
demonstrated that AR patients were at lower risk for 
CVD [8].
The differing age of onset of AR and CVD, may com-
plicate the relationship between them. The prevalence 
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of AR is highest in the second to fourth decades of life, 
and then gradually diminishes; this is in contrast to the 
prevalence of CVD, which increases later in life [9]. It is 
also well known that AR occurs frequently in subjects of 
higher socioeconomic class [10]. To reduce the fragmen-
tation found in previous studies, we aimed to investigate 
the association between AR prevalence and metabolic 
syndrome (MetS) in this large-scale population-based 
study with a consideration of the relevant risk factors.
Methods
Study design and subject selection
This study was based on data obtained from the Korean 
National Health and Nutrition Examination Survey 
2007–2013, which was a nationwide population-based 
survey conducted by the Korean Ministry of Health and 
Welfare. Participants were randomly selected through 
a stratified, multistage, probability-sampling design 
according to sampling units based on age group from 
household registries as well as economic status, sex, 
and geographic area [11]. This study was approved by 
the Institutional Review Board of Gachon University Gil 
Medical Center.
We identified 44,118 participants of 19 years of age or 
older. Of these, subjects who were diagnosed with overt 
CVD (stroke or myocardial infarction, n =  1192), other 
allergic diseases (atopic dermatitis or asthma, n = 2157) 
and those who had no available data on the two main 
variables (AR, n = 8072; MetS, n = 2107) were excluded. 
Thus, a dataset of 30,590 patients was used in the final 
analysis.
Data processing
Information on demographic characteristics (age, sex, 
household income, residency, education level, occupation 
and marital status), health behaviors (physical activity, 
smoking history, and alcohol consumption), and history 
of disease as diagnosed by a physician (AR, hypertension, 
type 2 diabetes, and dyslipidemia) was collected during 
the health interview. Waist circumference was measured 
at the narrowest point between the lower border of the 
rib cage and the iliac crest. BP was measured from the 
right arm after the subject had rested for 5 min in a sit-
ting position using a standard mercury sphygmomanom-
eter (Baumanometer, USA). Blood samples were obtained 
after a 12-h overnight fast, and fasting plasma glucose, 
triglyceride, and high-density lipoprotein cholesterol lev-
els were measured using a Hitachi 700-110 Chemistry 
Analyzer (Hitachi, Tokyo, Japan).
The definition for MetS and its components was based 
on the National Cholesterol Education Program Adult 
Treatment Panel III guidelines, and we used the eth-
nicity-specific values for waist circumference based on 
data from the Korean Society for the Study of Obesity 
[12]. MetS was thus defined by the presence of three or 
more of the following criteria: central obesity (waist cir-
cumference ≥90  cm for men and ≥80  cm for women); 
systolic BP  ≥130  mmHg or diastolic BP  ≥85  mmHg; 
fasting plasma glucose levels  ≥100  mg/dL; triglyceride 
levels  ≥150  mg/dL; and low high-density lipoprotein 
cholesterol levels (<40 mg/dL for men and <50 mg/dL for 
women). Subjects who reported taking antihypertensive, 
antidiabetic, or lipid-lowering medications were consid-
ered to satisfy the corresponding criterion.
Economic status was classified into “low” or “high” 
according to family size-adjusted mean monthly house-
hold income, which was calculated by dividing household 
income by the square root of the number of persons in 
the household. The region in which the subject lived was 
categorized as either urban or rural. The capital city, its 
surrounding metropolitan area, and other metropoli-
tan cities were grouped as urban areas; other areas were 
considered rural. Educational level was categorized as 
“middle school or lower” and “high school or beyond”. 
Marital status was classified as “married” or “unmarried”; 
“unmarried” included “single” and “divorced/separated/
widowed”. Occupations were reorganized into three 
groups: “unemployed”, “white-collar” or “blue-collar”.
Physical activity was categorized as “regular physical 
activity” when participants engaged in moderate inten-
sity activity more than five times per week, or vigorous 
activity more than three times per week, or “other”. The 
subject was considered a “never-smoker” if the subject 
had never smoked a cigarette, or otherwise an “ever-
smoker.” For alcohol consumption, subjects were con-
sidered “frequent drinkers” if they consumed more than 
seven drinks (men) or five drinks (women) in one sitting 
more than 2 days per week [13].
Statistical analyses
All analyses were performed using the STATA SE 9.2 
(STATA Corp., TX). Descriptive statistics were presented 
as percentages. Differences in characteristics depending 
on AR or MetS status were evaluated using a Chi square 
test. Odds ratios (ORs) of AR prevalence in subjects with 
metabolic conditions and their 95 % confidence intervals 
(CIs) were calculated using both unadjusted and adjusted 
logistic regression models. All statistical tests were two-
tailed, and results with P-values less than 0.05 were con-
sidered statistically significant.
Results
Table 1 presents the characteristics of the patients organ-
ized by AR and MetS status. The overall prevalences of 
AR and MetS were 11.7 and 30.2  %, respectively. Some 
characteristics showing a significant difference between 
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the status of both AR and MetS, had an inverse effect 
in the two conditions. For instance, in contrast to MetS, 
subjects being younger or of higher socioeconomic status 
was more common in the AR group than in the non-AR 
group.
The ORs for AR prevalence in subjects with MetS and 
its components are shown in Table 2. Multivariate logis-
tic analysis (Model I) revealed that the prevalence of AR 
was significantly lower in subjects with MetS (OR 0.84; 
95 % CI 0.76–0.93), high BP (OR 0.85; 95 % CI 0.77–0.94), 
or impaired fasting glucose (OR 0.81; 95 % CI 0.73–0.89). 
Among the metabolic components, high BP and impaired 
fasting glucose were independent predictors for reduced 
AR prevalence (Model II).
Discussion
As the mechanisms behind our findings remain unclear, 
our findings should be interpreted with caution. To the 
best of our knowledge, there is no evidence supporting 
the preventive effect of AR for CVD risks. Conversely, 
a growing body of evidence suggests that inflammatory 
mediators and cells involved in AR may be implicated 
in the process of atherosclerosis [14, 15]. Clinically, AR 
symptoms can also contribute to reduced sleep quality, 
which is associated with an increased risk of hyperten-
sion, type 2 diabetes, and obesity [16, 17].
It is reasonable to interpret our results to signify a 
decreased prevalence of AR in subjects with metabolic 
conditions. Medical service utilization by socioeconomic 
status may explain these findings [18]. As individuals in 
the higher socioeconomic class are more likely to main-
tain their health, their likelihood of developing CVD 
decreases [19]. On the other hand, they may be less likely 
to endure uncomfortable conditions that are not life-
threatening (i.e. AR), thus they are more often diagnosed 
with AR. A recent study reported that milder AR corre-
lates with a reduction in the risk of intracranial hemor-
rhage [20]. Mediating effects of medical utilization on the 
Table 1 Subject characteristics, organized by allergic rhinitis (AR) and metabolic syndrome (MetS) status
* From a Chi square test










 19–30 11.6 20.9 <0.001 17.2 2.4 <0.001
 30–39 18.7 31.3 24.9 9.3
 40–49 20.1 21.1 21.9 16.4
 50–59 19.1 14.9 16.4 23.9
 60–69 17.0 7.8 11.0 27.3
 ≥70 13.5 4.1 8.7 20.8
Female 56.7 61.6 <0.001 57.1 57.7 0.300
High economic status 55.9 65.4 <0.001 61.1 47.6 <0.001
Urban residency 76.4 85.3 <0.001 79.1 73.7 <0.001
Employed 60.6 61.1 0.529 63.5 54.1 <0.001
White-collar employment 19.3 29.7 <0.001 23.4 13.8 <0.001
Blue-collar employment 40.6 30.8 <0.001 39.4 39.6 0.694
Married 84.7 91.2 <0.001 89.0 78.6 <0.001
High education (≥high school) 62.2 85.8 <0.001 73.2 44.9 <0.001
Ever smoker 41.1 37.5 <0.001 40.5 41.2 0.271
Frequent drinker 5.0 3.7 0.001 4.4 6.0 <0.001
Regular physical activity 22.2 22.5 0.723 23.0 20.5 <0.001
Table 2 Odds ratios and  95  % confidence intervals of  the 
prevalence of  allergic rhinitis in  subjects with  metabolic 
conditions
HDL-C high-density lipoprotein cholesterol, Model I adjusted for demographic 
(age, sex, economic status, residency, type of job, marital status, and educational 
level) and health behavior (smoking status, alcoholic intake, and physical 
activity), Model II adjusted for the variables in Model 1 plus the other 4 metabolic 
conditions
* P < 0.01, ** P < 0.001
Unadjusted Model I Model II
Metabolic syn-
drome
0.53 (0.48–0.58)** 0.84 (0.76–0.93)*
Central obesity 0.69 (0.64–0.75)** 0.93 (0.85–1.02) 0.97 (0.89–1.07)
High blood pres-
sure
0.51 (0.47–0.55)** 0.85 (0.77–0.94)* 0.88 (0.79–0.97)*
Impaired fasting 
glucose
0.54 (0.50–0.59)** 0.81 (0.73–0.89)** 0.83 (0.75–0.92)**
Hypertriglyceri-
demia
0.69 (0.64–0.75)** 0.96 (0.88–1.05) 1.01 (0.91–1.11)
Low HDL-C 0.79 (0.73–0.85)** 1.00 (0.92–1.09) 1.03 (0.94–1.13)
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association with AR might be attenuated for central obe-
sity due to the difficulty of managing the disease [21] and 
for dyslipidemia because it is likely to be clinically over-
looked [22].
Additionally, the helper T cell paradigm suggests 
that type 1 and type 2 helper T cells reciprocally coun-
teract each other [23], which may explain the preven-
tive effects of impaired fasting glucose on AR risk in 
this study. Patients with type 1 diabetes are known to 
exhibit a lower prevalence of allergic disease [24]. A 
pilot study extended to type 2 diabetes demonstrated 
that higher levels of plasma glucose were associated 
with lower risk for AR [25], which is similar to our 
findings.
This study has several limitations. First, we relied 
on self-reporting of AR and also did not differentiate 
between AR subtypes. Second, the cross-sectional design 
does not permit us to infer causality between AR preva-
lence and CVD components. To determine causality, a 
clinical trial in which the incidence of AR between two 
groups (for example, one group with and one without 
impaired fasting glucose) is compared over time, would 
be required.
Conclusions
The present study is the largest to date to examine the 
relationship between AR prevalence and CVD risks. Our 
results underscore a significantly lower prevalence of 
AR in subjects with an identified metabolic dysfunction. 
Additional experimental and in-depth prospective stud-
ies are required to elucidate the mechanisms linking AR 
and CVD.
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